Donor‐Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte‐Like Cells



Heslop, J, Kia, R, Pridgeon, C, Sison-Young, R, Liloglou, T ORCID: 0000-0003-0460-1404, Elmasry, M, Fenwick, S, Mills, JS, Kitteringham, N, Goldring, C
et al (show 1 more authors) (2017) Donor‐Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte‐Like Cells. Stem Cells Translational Medicine, 6 (5). 1321 - 1331.

[img] Text
R2 proof of SCTM submission.pdf - Accepted Version

Download (3MB)

Abstract

Drug‐induced liver injury is the greatest cause of post‐marketing drug withdrawal; therefore, substantial resources are directed toward triaging potentially dangerous new compounds at all stages of drug development. One of the major factors preventing effective screening of new compounds is the lack of a predictive in vitro model of hepatotoxicity. Primary human hepatocytes offer a metabolically relevant model for which the molecular initiating events of hepatotoxicity can be examined; however, these cells vary greatly between donors and dedifferentiate rapidly in culture. Induced pluripotent stem cell (iPSC)‐derived hepatocyte‐like cells (HLCs) offer a reproducible, physiologically relevant and genotypically normal model cell; however, current differentiation protocols produce HLCs with a relatively immature phenotype. During the reprogramming of somatic cells, the epigenome undergoes dramatic changes; however, this “resetting” is a gradual process, resulting in an altered differentiation propensity, skewed toward the lineage of origin, particularly in early passage cultures. We, therefore, performed a comparison of human hepatocyte‐ and dermal fibroblast‐derived iPSCs, assessing the impact of epigenetic memory at all stages of HLC differentiation. These results provide the first isogenic assessment of the starting cell type in human iPSC‐derived HLCs. Despite a trend toward improvement in hepatic phenotype in albumin secretion and gene expression, few significant differences in hepatic differentiation capacity were found between hepatocyte and fibroblast‐derived iPSCs. We conclude that the donor and inter‐clonal differences have a greater influence on the hepatocyte phenotypic maturity than the starting cell type. Therefore, it is not necessary to use human hepatocytes for generating iPSC‐derived HLCs. Stem Cells Translational Medicine 2017;6:1321–1331

Item Type: Article
Uncontrolled Keywords: Primary human hepatocyte, Hepatocyte‐like cell, Epigenetic memory, Induced pluripotent stem cell, Donor‐dependent
Depositing User: Symplectic Admin
Date Deposited: 20 Dec 2016 16:41
Last Modified: 19 Feb 2021 18:11
DOI: 10.1002/sctm.16-0029
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3004957